Gregory J Mishkel

Summary

Affiliation: Southern Illinois University
Country: USA

Publications

  1. doi request reprint Correlates of late and very late thrombosis of drug eluting stents
    Gregory J Mishkel
    Prairie Heart Institute at St John s Hospital, Springfield, IL 62794 9420, USA
    Am Heart J 156:141-7. 2008
  2. ncbi request reprint Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease
    Gregory J Mishkel
    Prairie Cardiovascular Consultants, Ltd, Prairie Heart Institute at St John s Hospital, Springfield, IL 62794 9420, USA
    J Invasive Cardiol 19:331-7. 2007
  3. ncbi request reprint Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents
    Gregory J Mishkel
    Prairie Heart Institute at St John s Hospital, Springfield, Illinois 62794, USA
    J Am Coll Cardiol 49:181-4. 2007
  4. doi request reprint Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry
    Nilesh J Goswami
    Prairie Heart Institute at St John s Hospital, Springfield, IL 62794 9420, USA
    Catheter Cardiovasc Interv 75:93-100. 2010
  5. ncbi request reprint Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results
    Gregory J Mishkel
    Prairie Heart Institute at St John s Hospital, Springfield, IL, USA
    J Invasive Cardiol 19:63-8. 2007
  6. ncbi request reprint Protected carotid-artery stenting versus endarterectomy in high-risk patients
    Jay S Yadav
    Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    N Engl J Med 351:1493-501. 2004
  7. ncbi request reprint Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)
    Atsushi Hirohata
    Center for Research in Cardiovascular Intervention, Stanford University, Stanford, California, USA
    Am J Cardiol 98:1464-7. 2006
  8. ncbi request reprint Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 95:709-15. 2005
  9. doi request reprint Long-term results of carotid stenting versus endarterectomy in high-risk patients
    Hitinder S Gurm
    University of Michigan School of Medicine, Ann Arbor, USA
    N Engl J Med 358:1572-9. 2008
  10. ncbi request reprint Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial
    Mark A Turco
    Center for Cardiac and Vascular Research, Washington Adventist Hospital, Takoma Park, Maryland 20912, USA
    J Am Coll Cardiol 49:1676-83. 2007

Collaborators

Detail Information

Publications10

  1. doi request reprint Correlates of late and very late thrombosis of drug eluting stents
    Gregory J Mishkel
    Prairie Heart Institute at St John s Hospital, Springfield, IL 62794 9420, USA
    Am Heart J 156:141-7. 2008
    ..Late and very late thrombosis of coronary drug-eluting stents (DES) has received much attention but essentially remains unpredictable. We sought to identify correlates of stent thrombosis (ST) developing >30 days after DES implantation...
  2. ncbi request reprint Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease
    Gregory J Mishkel
    Prairie Cardiovascular Consultants, Ltd, Prairie Heart Institute at St John s Hospital, Springfield, IL 62794 9420, USA
    J Invasive Cardiol 19:331-7. 2007
    ..Randomized trials of drug-eluting stents (DES) excluded patients with severe renal insufficiency. We sought to evaluate the impact of baseline renal function on clinical outcomes in recipients of coronary DES...
  3. ncbi request reprint Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents
    Gregory J Mishkel
    Prairie Heart Institute at St John s Hospital, Springfield, Illinois 62794, USA
    J Am Coll Cardiol 49:181-4. 2007
    ..The purpose of this study was to examine the outcomes of patients who developed coronary in-stent restenosis (ISR) or stent thrombosis (STH) inside drug-eluting stents (DES)...
  4. doi request reprint Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry
    Nilesh J Goswami
    Prairie Heart Institute at St John s Hospital, Springfield, IL 62794 9420, USA
    Catheter Cardiovasc Interv 75:93-100. 2010
    ..This study was designed to compare long-term clinical outcomes of drug-eluting stents (DES) versus bare metal stents (BMS) in patients with saphenous vein graft (SVG) disease in the "real world."..
  5. ncbi request reprint Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results
    Gregory J Mishkel
    Prairie Heart Institute at St John s Hospital, Springfield, IL, USA
    J Invasive Cardiol 19:63-8. 2007
    ..This study compared the utilization, clinical outcomes and costs associated with the planned use of bivalirudin versus heparin + GP IIb/IIIa inhibition in drug-eluting stent (DES) patients without acute myocardial infarction (MI)...
  6. ncbi request reprint Protected carotid-artery stenting versus endarterectomy in high-risk patients
    Jay S Yadav
    Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    N Engl J Med 351:1493-501. 2004
    ..Stenting with the use of an emboli-protection device is a less invasive revascularization strategy than endarterectomy in carotid-artery disease...
  7. ncbi request reprint Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)
    Atsushi Hirohata
    Center for Research in Cardiovascular Intervention, Stanford University, Stanford, California, USA
    Am J Cardiol 98:1464-7. 2006
    ..This strategy appears to be associated with less neointimal hyperplasia near the distal stent edge...
  8. ncbi request reprint Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 95:709-15. 2005
    ..Paclitaxel-eluting stents attenuate the increased risk associated with obesity, such that the intermediate-term prognosis after percutaneous coronary intervention is independent of weight...
  9. doi request reprint Long-term results of carotid stenting versus endarterectomy in high-risk patients
    Hitinder S Gurm
    University of Michigan School of Medicine, Ann Arbor, USA
    N Engl J Med 358:1572-9. 2008
    ..We now report the 3-year results...
  10. ncbi request reprint Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial
    Mark A Turco
    Center for Cardiac and Vascular Research, Washington Adventist Hospital, Takoma Park, Maryland 20912, USA
    J Am Coll Cardiol 49:1676-83. 2007
    ..The goal of this research was to assess non-inferiority of the next-generation TAXUS Liberté stent (Boston Scientific Corp., Natick, Massachusetts) versus the TAXUS Express stent (Boston Scientific Corp.)...